Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Retrieved on: 2024-09-19 20:58:23

Tags for this article:

Click the tags to see associated articles and topics

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule. View article details on hiswai:

Excerpt

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution. Image for ...

Article found on: quantisnow.com